Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 21
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/1/1991
1.
Phase II Study of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 03/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-89U3
NCI-T89-0166D, T89-0166
Last Modified:
11/1/1990
2.
Phase II Study of Piroxantrone in Patients with Stage IV non-Small Cell Lung Cancer (Summary Last Modified 11/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8866
Last Modified:
2/1/1991
3.
Phase II Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 02/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8945
Last Modified:
9/13/2006
4.
Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Metastatic non-Small Cell Bronchogenic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
any age
NCI
EST-1589
Last Modified:
8/1/1990
5.
Phase II Trial of Piroxantrone for Advanced Soft-Tissue Sarcomas (Summary Last Modified 08/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-8930
Last Modified:
8/1/1990
6.
Phase II Study of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 08/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-8932
Last Modified:
1/1/1991
7.
Phase II Evaluation of Piroxantrone in Patients with Pancreatic Adenocarcinoma (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-8933
Last Modified:
1/1/1991
8.
Phase II Evaluation of Piroxantrone in Patients with Gastric Carcinoma (Summary Last Modified 01/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8936
Last Modified:
1/1/1992
9.
Phase II Study of Piroxantrone in Patients with Refractory Carcinoma of the Breast (Summary Last Modified 01/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-8911
Last Modified:
10/1/1991
10.
Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Recurrent Ovarian Cancer (Summary Last Modified 10/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8904
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute